Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 321 - 328 of 11440 results
NYC “Know Your Rights” Poster and Bill of Rights Website Now Live
April 22, 2024| Blog| Viewpoint
Mintz Direct
April 22, 2024| Blog| Viewpoint
Doing Life Sciences Deals in 2024
April 22, 2024| Blog| Viewpoint
Preparing a VC-Backed Company for an Exit Event
April 22, 2024| Alert| Viewpoint
Canada’s Federal Budget 2024: More Changes to the Stock Option Rules = More Headaches for Employers
April 22, 2024| Alert| Viewpoint
The Capitol Forum Interviews Mintz's Bruce Sokler
April 22, 2024| News
The Climate Rule Is Stayed. Companies Should Still Develop Transition Plans.
April 22, 2024| News
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.